Search Results

Multaq Linked To Increased Risk Of Heart Problems And Death The FDA issued a warning to healthcare professionals yesterday about the drug Multaq (dronedarone) following results in a safety review that showed dramatically increased risks of cardiovascular events, including death, in patients with permanent atrial fibrillation (AF) who take the drug. (more...)

Drug injuries possible with heart drug Dronedarone January 20, 2011 With the development of new drugs, there is hope for cures or at least treatments for patients coping with chronic illness. However, new drugs may also have risks that don’t immediately present themselves. Unfortunately, a newer drug is being recalled due to its risk of drug injuries, including liver failure. According to (more...)